Thermo Fisher Scientific Inc (TMO)

Fixed asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	42,879,000	42,370,000	42,346,000	42,492,000	42,857,000	43,421,000	43,524,000	43,807,000	44,915,000	44,167,000	42,820,000	41,123,000	39,211,000	39,059,000	38,250,000	35,894,000	32,218,000	28,497,000	26,248,000	25,647,000
Property, plant and equipment	US$ in thousands	—	—	—	—	—	9,167,000	9,292,000	9,354,000	9,280,000	8,628,000	8,529,000	8,448,000	8,333,000	7,049,000	6,560,000	6,133,000	5,912,000	5,180,000	4,887,000	4,736,000
Fixed asset turnover		—	—	—	—	—	4.74	4.68	4.68	4.84	5.12	5.02	4.87	4.71	5.54	5.83	5.85	5.45	5.50	5.37	5.42

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $42,879,000K ÷ $—K
= —

Thermo Fisher Scientific Inc's fixed asset turnover ratio has demonstrated some fluctuation over the past few years. The ratio, which measures how efficiently the company is using its fixed assets to generate revenue, shows a generally positive trend from March 2020 to June 2022, consistently staying above 5. However, there was a slight decline in the ratio from June 2022 to December 2022, dropping to 4.84. This suggests a potential decrease in the efficiency of utilizing fixed assets during this period.

From March 2023 to September 2023, the fixed asset turnover ratio remained relatively stable around 4.70, indicating that the company maintained a moderate level of efficiency in generating sales from its fixed assets. However, there was a slight increase in the ratio from September 2023 to December 2023, reaching 4.74.

Notably, there is missing data for the fixed asset turnover ratio from December 2023 onwards, which limits the ability to provide a complete analysis for the most recent period. It would be important to monitor future financial reports to assess any potential trends or changes in Thermo Fisher Scientific Inc's efficiency in utilizing its fixed assets for revenue generation.